Related references
Note: Only part of the references are listed.Somatic activating ARAF mutations in Langerhans cell histiocytosis
David S. Nelson et al.
BLOOD (2014)
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Noah A. Brown et al.
BLOOD (2014)
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Marie-Luise Berres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Cladribine Is Effective against Cystic Pulmonary Langerhans Cell Histiocytosis
Gwenael Lorillon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pulmonary langerhans cell histiocytosis
Harpreet S. Suri et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Abnormal Fluorodeoxyglucose PET in Pulmonary Langerhans Cell Histiocytosis
Bryan J. Krajicek et al.
CHEST (2009)
Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy
R. Lazor et al.
THORAX (2009)
Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker
Michelle R. Aerni et al.
RESPIRATORY MEDICINE (2008)
2-chlorodeoxyadenosine therapy for disseminated langerhans cell histiocytosis
A Pardanani et al.
MAYO CLINIC PROCEEDINGS (2003)
Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine
NSL Goh et al.
RESPIROLOGY (2003)
Clinico-epidemiological features of pulmonary histiocytosis X
R Watanabe et al.
INTERNAL MEDICINE (2001)
Is high-resolution computed tomography a reliable tool to predict the histopathologic activity of pulmonary Langerhans cell histiocytosis?
P Soler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Severe pulmonary hypertension in histiocytosis X
M Fartoukh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
